BioSpace News Archive

Press Releases

Aldeyra Therapeutics Receives Fast Track Designation for ADX‑2191 for the Treatment of Retinitis Pigmentosa

August 20, 2025
·
8 min read
Press Releases

Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)

August 20, 2025
·
7 min read
Press Releases

Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025

August 20, 2025
·
6 min read
Press Releases

Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer

August 20, 2025
·
6 min read
Press Releases

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

August 20, 2025
·
4 min read
Press Releases

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

August 20, 2025
·
6 min read
Press Releases

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

August 20, 2025
·
4 min read
Press Releases

Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC

August 20, 2025
·
3 min read
Press Releases

COUR Pharma Doses First Patient in Clinical Trial Evaluating CNP-103 in People Recently Diagnosed with Type 1 Diabetes

August 20, 2025
·
3 min read
Press Releases

Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer

August 20, 2025
·
3 min read